Ann Coloproctol.  2023 Feb;39(1):89-93. 10.3393/ac.2022.00563.0080.

Clinical outcomes with of the Contix Faecal Incontinence Management System: preliminary results

Affiliations
  • 1Department of Surgery, Laniado Hospital, Sanz Medical Center, Netanya, Israel
  • 2Gastroenterology Institute, Sheba Medical Center, Ramat Gan, Israel
  • 3Forconti Medical, Caesarea, Israel
  • 4Neurogastroenterology and Pelvic Floor Disorders Unit, Laniado Hospital, Sanz Medical Center, Netanya, Israel

Abstract

Fecal incontinence (FI) has a significant long-term impact on patient quality of life for which there is a range of medical and surgical management alternatives. We report the preliminary outcome using the ForConti Contix Faecal Incontinence Management System (FIMS) in FI patients who had failed conservative therapy and who were recruited at 2 tertiary institutions between September 2018 and September 2020. Comparative assessments were made before and after 2 week periods of treatment using bowel diaries and subjective Wexner and Faecal Incontinence Quality of Life scores. Of 17 patients enrolled, 11 completed an 8-week assessment with a significant fall in the average percentage of FI days reported from 84% before treatment to 16.8% at the first posttreatment assessment and down to 13.2% by the second assessment period. This finding correlated with a similar reduction in the total weekly number of episodes of frank FI, minor soiling, and fecal urgency reported by patients along with concomitant improvements in the Wexner scores. For those using the device, there was less concern about accidental bowel leakage, high rates of satisfaction, and minimal problems with the device. Initial results are encouraging warranting further study.

Keyword

Fecal incontinence; Anal plug; Faecal Incontinence Management System; ForConti Contix; Accdental bowel leakage
Full Text Links
  • AC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr